SCHEMBL20041954

SCHEMBL20041954

CC(C)CC(O)C1CCN(C)C1

nearest known ligand 0.33

Predicted protein targets (top 2)

geneUniProtsupporting neighboursconfidence
NCF1 P14598 1/20 0.33
POLB P06746 1/20 0.33

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL20041835 0.80 NCF1 (0.35) NCF1
SCHEMBL14837985 0.80 NCF1 (0.35) NCF1
SCHEMBL7513512 0.77
SCHEMBL8504951 0.74
SCHEMBL13153898 0.74 POLB (0.39) POLB
SCHEMBL11890359 0.74
SCHEMBL12257627 0.74
SCHEMBL11890362 0.74
SCHEMBL20041861 0.74 NCF1 (0.32) NCF1
SCHEMBL25091220 0.73 NCF1 (0.39) NCF1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2454234-B1 3-PHENOXYMETHYLPYRROLIDINE COMPOUNDS THERAVANCE BIOPHARMA R&D IP LLC (US) 2018-04-11 EP disclosed